Request Demo
Last update 05 Mar 2026
Shanxi Kangbao Biological Product Co. Ltd.
Last update 05 Mar 2026
Overview
Tags
Hemic and Lymphatic Diseases
Infectious Diseases
Other Diseases
Non-recombinant coagulation factor
Small molecule drug
Interferons
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT07433387
An Exploratory Multicenter, Open-label, Sequential Cohort Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetic Characteristics of LP-98 forInjection in Antiretroviral Therapy-Naive HIV-Infected Individuals
CTR20253967
硝酸甘油喷雾剂在中国健康参与者中的单次给药、随机、开放、两制剂、两序列、四周期、完全重复交叉的生物等效性研究
[Translation] A single-dose, randomized, open-label, two-dose, two-sequence, four-period, fully repeated crossover bioequivalence study of nitroglycerin spray in healthy Chinese participants
CTR20252908
评价人纤维蛋白原治疗慢性肝病患者获得性低纤维蛋白原血症的有效性和安全性的随机、双盲、阳性药平行对照、非劣效、多中心临床试验
[Translation] A randomized, double-blind, active-drug parallel-controlled, non-inferiority, multicenter clinical trial to evaluate the efficacy and safety of human fibrinogen in the treatment of acquired hypofibrinogenemia in patients with chronic liver disease
100 Clinical Results associated with Shanxi Kangbao Biological Product Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanxi Kangbao Biological Product Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shanxi Kangbao Biological Product Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 16 Mar 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
3
Phase 1
Phase 2
2
3
Approved
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free